Determination of a new oral iron chelator, ICL670, and its iron complex in plasma by high-performance liquid chromatography and ultraviolet detection
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-05-05
著者
-
Maurer G
Drug Metabolism And Pharmacokinetics Novartis Pharma Sa
-
Rouan M.
Drug Metabolism And Pharmacokinetics Novartis Pharma Sa
-
MARFIL F.
Drug Metabolism and Pharmacokinetics, Novartis Pharma SA
-
MANGONI P.
Drug Metabolism and Pharmacokinetics, Novartis Pharma SA
-
SECHAUD R.
Clinical Pharmacology, Novartis Pharma AG
-
HUMBERT H.
Drug Metabolism and Pharmacokinetics, Novartis Pharma SA
-
MAURER G.
Drug Metabolism and Pharmacokinetics, Novartis Pharma SA
-
Marfil F.
Drug Metabolism And Pharmacokinetics Novartis Pharma Sa
-
Humbert H
Drug Metabolism And Pharmacokinetics Novartis Pharma Sa
-
Humbert H.
Drug Metabolism And Pharmacokinetics Novartis Pharma Sa
-
Sechaud R.
Clinical Pharmacology Novartis Pharma Ag
-
Maurer G.
Drug Metabolism And Pharmacokinetics Novartis Pharma Sa
-
Mangoni P.
Drug Metabolism And Pharmacokinetics Novartis Pharma Sa
関連論文
- Determination of a new oral iron chelator, ICL670, and its iron complex in plasma by high-performance liquid chromatography and ultraviolet detection
- Practice of solid-phase extraction and protein precipitation in the 96-well format combined with high-performance liquid chromatography-ultraviolet detection for the analysis of drugs in plasma and brain
- Development of a high throughput 96-well plate sample preparation method for the determination of trileptal (oxcarbazepine) and its metabolites in human plasma